vs
Side-by-side financial comparison of HUTCHMED (China) Ltd (HCM) and Enpro Inc. (NPO). Click either name above to swap in a different company.
Enpro Inc. is the larger business by last-quarter revenue ($295.4M vs $270.8M, roughly 1.1× HUTCHMED (China) Ltd). HUTCHMED (China) Ltd runs the higher net margin — 0.7% vs -10.8%, a 11.6% gap on every dollar of revenue. On growth, Enpro Inc. posted the faster year-over-year revenue change (14.3% vs -16.5%).
HUTCHMED (China) LtdHCMEarnings & Financial Report
HUTCHMED (China) Ltd is a biopharmaceutical firm focused on discovering, developing and commercializing targeted and immunotherapies for oncology and immunological diseases. It operates across China and global markets, with multiple marketed oncology drugs and a robust pipeline of late-stage clinical candidates addressing unmet patient needs.
Enpro is a US-based industrial technology company that designs and manufactures products and materials for technology-intensive sectors. The company serves industries such as semiconductors, aerospace, power generation, heavy-duty trucking, agricultural machinery, chemical processing, pulp and paper, and life sciences from 61 primary manufacturing facilities located in 12 countries, worldwide. It is organized under three segments: Sealing Technologies, Advanced Surface Technologies, and Engin...
HCM vs NPO — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $270.8M | $295.4M |
| Net Profit | $2.0M | $-32.0M |
| Gross Margin | 37.7% | 42.1% |
| Operating Margin | -13.2% | 11.2% |
| Net Margin | 0.7% | -10.8% |
| Revenue YoY | -16.5% | 14.3% |
| Net Profit YoY | -83.6% | -330.2% |
| EPS (diluted) | $0.00 | $-1.50 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $270.8M | $295.4M | ||
| Q3 25 | — | $286.6M | ||
| Q2 25 | $277.7M | $288.1M | ||
| Q1 25 | $324.5M | $273.2M | ||
| Q4 24 | — | $258.4M | ||
| Q3 24 | — | $260.9M | ||
| Q2 24 | $305.7M | $271.9M | ||
| Q1 24 | — | $257.5M |
| Q4 25 | $2.0M | $-32.0M | ||
| Q3 25 | — | $21.6M | ||
| Q2 25 | $455.0M | $26.4M | ||
| Q1 25 | $11.9M | $24.5M | ||
| Q4 24 | — | $13.9M | ||
| Q3 24 | — | $19.8M | ||
| Q2 24 | $25.8M | $26.7M | ||
| Q1 24 | — | $12.5M |
| Q4 25 | 37.7% | 42.1% | ||
| Q3 25 | — | 41.9% | ||
| Q2 25 | 0.1% | 43.3% | ||
| Q1 25 | 48.0% | 43.3% | ||
| Q4 24 | — | 42.3% | ||
| Q3 24 | — | 42.3% | ||
| Q2 24 | 41.1% | 43.8% | ||
| Q1 24 | — | 41.2% |
| Q4 25 | -13.2% | 11.2% | ||
| Q3 25 | — | 14.3% | ||
| Q2 25 | -1.3% | 15.9% | ||
| Q1 25 | -5.0% | 15.3% | ||
| Q4 24 | — | 12.5% | ||
| Q3 24 | — | 13.1% | ||
| Q2 24 | -9.0% | 17.7% | ||
| Q1 24 | — | 10.9% |
| Q4 25 | 0.7% | -10.8% | ||
| Q3 25 | — | 7.5% | ||
| Q2 25 | 163.8% | 9.2% | ||
| Q1 25 | 3.7% | 9.0% | ||
| Q4 24 | — | 5.4% | ||
| Q3 24 | — | 7.6% | ||
| Q2 24 | 8.4% | 9.8% | ||
| Q1 24 | — | 4.9% |
| Q4 25 | $0.00 | $-1.50 | ||
| Q3 25 | — | $1.01 | ||
| Q2 25 | $0.52 | $1.25 | ||
| Q1 25 | $0.01 | $1.15 | ||
| Q4 24 | — | $0.65 | ||
| Q3 24 | — | $0.94 | ||
| Q2 24 | $0.03 | $1.27 | ||
| Q1 24 | — | $0.59 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $1.4B | $114.7M |
| Total DebtLower is stronger | $93.2M | $655.3M |
| Stockholders' EquityBook value | $1.2B | $1.5B |
| Total Assets | $1.8B | $2.7B |
| Debt / EquityLower = less leverage | 0.08× | 0.42× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $1.4B | $114.7M | ||
| Q3 25 | — | $132.9M | ||
| Q2 25 | $1.4B | $107.1M | ||
| Q1 25 | $836.1M | $240.3M | ||
| Q4 24 | — | $236.3M | ||
| Q3 24 | — | $206.9M | ||
| Q2 24 | $802.5M | $175.9M | ||
| Q1 24 | — | $163.9M |
| Q4 25 | $93.2M | $655.3M | ||
| Q3 25 | — | — | ||
| Q2 25 | $93.4M | — | ||
| Q1 25 | $82.8M | — | ||
| Q4 24 | — | $640.1M | ||
| Q3 24 | — | — | ||
| Q2 24 | $82.1M | — | ||
| Q1 24 | — | $644.9M |
| Q4 25 | $1.2B | $1.5B | ||
| Q3 25 | — | $1.5B | ||
| Q2 25 | $1.2B | $1.5B | ||
| Q1 25 | $759.9M | $1.5B | ||
| Q4 24 | — | $1.4B | ||
| Q3 24 | — | $1.5B | ||
| Q2 24 | $740.1M | $1.4B | ||
| Q1 24 | — | $1.4B |
| Q4 25 | $1.8B | $2.7B | ||
| Q3 25 | — | $2.4B | ||
| Q2 25 | $1.8B | $2.4B | ||
| Q1 25 | $1.3B | $2.5B | ||
| Q4 24 | — | $2.5B | ||
| Q3 24 | — | $2.5B | ||
| Q2 24 | $1.3B | $2.5B | ||
| Q1 24 | — | $2.5B |
| Q4 25 | 0.08× | 0.42× | ||
| Q3 25 | — | — | ||
| Q2 25 | 0.08× | — | ||
| Q1 25 | 0.11× | — | ||
| Q4 24 | — | 0.45× | ||
| Q3 24 | — | — | ||
| Q2 24 | 0.11× | — | ||
| Q1 24 | — | 0.46× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $8.2M | — |
| Free Cash FlowOCF − Capex | $3.4M | — |
| FCF MarginFCF / Revenue | 1.2% | — |
| Capex IntensityCapex / Revenue | 1.8% | 4.1% |
| Cash ConversionOCF / Net Profit | 4.21× | — |
| TTM Free Cash FlowTrailing 4 quarters | $-96.2M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $8.2M | — | ||
| Q3 25 | — | $65.3M | ||
| Q2 25 | $-72.9M | $52.2M | ||
| Q1 25 | $40.3M | $21.0M | ||
| Q4 24 | — | $59.4M | ||
| Q3 24 | — | $54.0M | ||
| Q2 24 | $-39.8M | $43.2M | ||
| Q1 24 | — | $6.3M |
| Q4 25 | $3.4M | — | ||
| Q3 25 | — | $53.4M | ||
| Q2 25 | $-82.2M | $42.3M | ||
| Q1 25 | $32.5M | $13.0M | ||
| Q4 24 | — | $49.1M | ||
| Q3 24 | — | $48.3M | ||
| Q2 24 | $-49.9M | $38.3M | ||
| Q1 24 | — | $-1.9M |
| Q4 25 | 1.2% | — | ||
| Q3 25 | — | 18.6% | ||
| Q2 25 | -29.6% | 14.7% | ||
| Q1 25 | 10.0% | 4.8% | ||
| Q4 24 | — | 19.0% | ||
| Q3 24 | — | 18.5% | ||
| Q2 24 | -16.3% | 14.1% | ||
| Q1 24 | — | -0.7% |
| Q4 25 | 1.8% | 4.1% | ||
| Q3 25 | — | 4.2% | ||
| Q2 25 | 3.3% | 3.4% | ||
| Q1 25 | 2.4% | 2.9% | ||
| Q4 24 | — | 4.0% | ||
| Q3 24 | — | 2.2% | ||
| Q2 24 | 3.3% | 1.8% | ||
| Q1 24 | — | 3.2% |
| Q4 25 | 4.21× | — | ||
| Q3 25 | — | 3.02× | ||
| Q2 25 | -0.16× | 1.98× | ||
| Q1 25 | 3.38× | 0.86× | ||
| Q4 24 | — | 4.27× | ||
| Q3 24 | — | 2.73× | ||
| Q2 24 | -1.54× | 1.62× | ||
| Q1 24 | — | 0.50× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
HCM
Segment breakdown not available.
NPO
| Sealing Technologies Segment | $187.0M | 63% |
| General Industrial | $71.3M | 24% |
| Power Generation | $19.9M | 7% |
| Oiland Gas Market | $15.0M | 5% |
| Semiconductors | $2.2M | 1% |
